Literature DB >> 19635543

Inhibition of aortic intimal hyperplasia and cell cycle protein and extracellular matrix protein expressions by BuYang HuanWu Decoction.

Lu Wu1, Wei Zhang, Hua Li, Bei-Yang Chen, Guo-Min Zhang, Ying-Hong Tang, Fu-Yuan He, Chang-Qing Deng.   

Abstract

AIM OF THE STUDY: The inhibitive effect of BuYang HuanWu Decoction (BYHWD) and its major components on vascular intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix protein.
MATERIALS AND METHODS: Sprague-Dawley rats were randomly divided into sham-operated, control, alkaloid, glycoside, BYHWD and atorvastatin groups. Rat aorta intima in all groups were injured by insesion of domestic balloon catheter into the aortae except sham-operated rats. Drugs were administrated orally from the second day after vascular injury and continued for 14 days. The injured segments of aortae were collected on the sixteenth day after operation to observe the morphological changes of vascular structure and to examine the expressions of proteins in vascular cells associated with cell cycle including proliferating cell nuclear antigen(PCNA), cyclinD(1) and cyclinE, and extracellular matrix(ECM) proteins including collagen I (Col-I) and fibronectin (FN), further to discover the involved biologically active substances and the potential mechanisms.
RESULTS: Alkaloid and glycosid isolated from BYHWD were more effective than BYHWD in the inhibition of intimal hyperplasia and the expressions of PCNA, cyclinD(1), cyclinE, Col-I and FN, suggesting that alkaloid and glycoside may be the main components of BYHWD responsible for the observed inhibition of excessive hyperplasia of vascular intima.
CONCLUSIONS: The mechanism associated with the anti-hyperplasia activity of BYHWD and its effective components may be related to the blockage of cell cycles of VSMC, and the inhibition of the ECM protein synthesis, even the increased degradation of ECM proteins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635543     DOI: 10.1016/j.jep.2009.07.022

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  7 in total

1.  Identification of metabolites of Buyang Huanwu decoction in rat urine using liquid chromatography-quadrupole time-of-flight mass spectrometry.

Authors:  Xiao-Dong Wen; E-Hu Liu; Jie Yang; Chang-Yin Li; Wen Gao; Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan; Ping Li
Journal:  J Pharm Biomed Anal       Date:  2012-04-25       Impact factor: 3.935

2.  Buyang Huanwu Decoction attenuates H2O2-induced apoptosis by inhibiting reactive oxygen species-mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells.

Authors:  Jian Shen; Yu Zhu; Kaiyuan Huang; Hao Jiang; Chengzhang Shi; Xiaoxing Xiong; Renya Zhan; Jianwei Pan
Journal:  BMC Complement Altern Med       Date:  2016-05-31       Impact factor: 3.659

3.  Effects of Xiaoshuan enteric-coated capsule on neurovascular functions assessed by quantitative multiparametric MRI in a rat model of permanent cerebral ischemia.

Authors:  Jian Zhang; Haiyan Zou; Qiuxia Zhang; Lei Wang; Jianfeng Lei; Yali Wang; Junyao Ouyang; Yi Zhang; Hui Zhao
Journal:  BMC Complement Altern Med       Date:  2016-07-08       Impact factor: 3.659

4.  Buyang Huanwu Decoction promotes neurogenesis via sirtuin 1/autophagy pathway in a cerebral ischemia model.

Authors:  Han Li; Dong Peng; Shi-Jie Zhang; Yang Zhang; Qi Wang; Li Guan
Journal:  Mol Med Rep       Date:  2021-09-13       Impact factor: 2.952

5.  Inhibition of Aortic Intimal Hyperplasia and Vascular Smooth Muscle Proliferation and Extracellular Matrix Protein Expressions by Astragalus-Angelica Combination.

Authors:  Huifang Yan; Xiwei Peng; Hao Xu; Jiahuan Zhu; Changqing Deng
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-13       Impact factor: 2.629

6.  Identification of multiple ingredients for a Traditional Chinese Medicine preparation (bu-yang-huan-wu-tang) by liquid chromatography coupled with tandem mass spectrometry.

Authors:  Lee-Hsin Shaw; Wei-Ming Chen; Tung-Hu Tsai
Journal:  Molecules       Date:  2013-09-12       Impact factor: 4.411

7.  Huotan Jiedu Tongluo Decoction Inhibits Balloon-Injury-Induced Carotid Artery Intimal Hyperplasia in the Rat through the PERK-eIF2α-ATF4 Pathway and Autophagy Mediation.

Authors:  Tenghui Tian; Keying Yu; Miao Zhang; Xiao Shao; Liping Chang; Rui Shi; Baojin Yao; Yue Deng
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-20       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.